[1] PAN BT,TENG K,WU C,et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes[J]. J Cell Biol,1985,101(3):942-948.
|
[2] DOYLE LM,WANG MZ. Overview of extracellular vesicles,their origin,composition,purpose,and methods for exosome isolation and analysis[J]. Cells,2019,8(7):1-24.
|
[3] BARILE L,VASSALLI G. Exosomes:Therapy delivery tools and biomarkers of diseases[J]. Pharmacol Ther,2017,174:63-78.
|
[4] YOON SB,CHANG JH. Extracellular vesicles in bile:A game changer in the diagnosis of indeterminate biliary stenoses?[J]. Hepatobiliary Surg Nutr,2017,6(6):408-410.
|
[5] VAN NIEL G,D’ANGELO G,RAPOSO G. Shedding light on the cell biology of extracellular vesicles[J]. Nat Rev Mol Cell Biol,2018,19(4):213-228.
|
[6] PEGTEL DM,GOULD SJ. Exosomes[J]. Annu Rev Biochem,2019,88:487-514.
|
[7] GUESCINI M,GENEDANI S,STOCCHI V,et al. Astrocytes and Glioblastoma cells release exosomes carrying mt DNA[J]. J Neural Transm(Vienna),2010,117(1):1-4.
|
[8] MACIAS M,REBMANN V,MATEOS B,et al. Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis[J]. Clin Chem Lab Med,2019,57(10):1539-1545.
|
[9] DING M,WANG C,LU X,et al. Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling[J]. Anal Bioanal Chem,2018,410(16):3805-3814.
|
[10] CONSOLE L,SCALISE M,INDIVERI C. Exosomes in inflammation and role as biomarkers[J]. Clin Chim Acta,2019,488:165-171.
|
[11] SIL S,DAGUR RS,LIAO K,et al. Strategies for the use of extracellular vesicles for the delivery of therapeutics[J]. J Neuroimmune Pharmacol,2019.[Epub ahead of print]
|
[12] YANG Y,HAN Q,HOU Z,et al. Exosomes mediate hepatitis B virus(HBV)transmission and NK-cell dysfunction[J].Cell Mol Immunol,2017,14(5):465-475.
|
[13] KAKIZAKI M,YAMAMOTO Y,YABUTA S,et al. The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes[J]. PLo S One,2018,13(12):e0205886.
|
[14] SHI Y,DU L,LV D,et al. Exosomal interferon-induced transmembrane protein 2 transmitted to dendritic cells inhibits interferon alpha pathway activation and blocks anti-hepatitis B virus efficacy of exogenous interferon alpha[J]. Hepatology,2019,69(6):2396-2413.
|
[15] KARAMICHALI E,CHIHAB H,KAKKANAS A,et al. HCV defective genomes promote persistent infection by modulating the viral life cycle[J]. Front Microbiol,2018,9:2942.
|
[16] DEVHARE PB,SASAKI R,SHRIVASTAVA S,et al. Exosomemediated intercellular communication between hepatitis C virusinfected hepatocytes and hepatic stellate cells[J]. J Virol,2017,91(6):e02225-16.
|
[17] DENG L,JIANG W,WANG X,et al. Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes[J]. J Hepatol,2019,71(1):52-61.
|
[18] SAHA B,MOMEN-HERAVI F,FURI I,et al. Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90[J]. Hepatology,2018,67(5):1986-2000.
|
[19] BALA S,CSAK T,SAHA B,et al. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis[J]. J Hepatol,2016,64(6):1378-1387.
|
[20] BABUTA M,FURI I,BALA S,et al. Dysregulated autophagy and lysosome function are linked to exosome production by micro-RNA 155 in alcoholic liver disease[J]. Hepatology,2019,70(6):2123-2141.
|
[21] POVERO D,EGUCHI A,NIESMAN IR,et al. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells[J].Sci Signal,2013,6(296):ra88.
|
[22] LIU XL,PAN Q,CAO HX,et al. Lipotoxic hepatocyte-derived exosomal miR-192-5p activates macrophages via Rictor/Akt/Fox O1 signaling in NAFLD[J]. Hepatology,2019.[Epub ahead of print]
|
[23] WAN L,XIA T,DU Y,et al. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2:A role for exosomes in metabolic switch of liver nonparenchymal cells[J]. FASEB J,2019,33(7):8530-8542.
|
[24] ZHANG XW,ZHOU JC,PENG D,et al. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation[J]. Autophagy,2019.[Epub ahead of print]
|
[25] KIM JH,LEE CH,LEE SW. Exosomal transmission of microRNA from HCV replicating cells stimulates transdifferentiation in hepatic stellate cells[J]. Mol Ther Nucleic Acids,2019,14:483-497.
|
[26] HOLMAN NS,CHURCH RJ,NAUTIYAL M,et al. Hepatocytederived exosomes promote liver immune tolerance:Possible implications for idiosyncratic drug-induced liver injury[J]. Toxicol Sci,2019,170(2):499-508.
|
[27] CHARRIER A,CHEN R,CHEN L,et al. Exosomes mediate intercellular transfer of pro-fibrogenic connective tissue growth factor(CCN2)between hepatic stellate cells,the principal fibrotic cells in the liver[J]. Surgery,2014,156(3):548-555.
|
[28] LIU R,LI X,ZHU W,et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis[J]. Hepatology,2019,70(4):1317-1335.
|
[29] WANG G,JIN S,LING X,et al. Proteomic profiling of LPS-induced macrophage-derived exosomes indicates their involvement in acute liver injury[J]. Proteomics,2019,19(3):e1800274.
|
[30] CHO YE,SEO W,KIM DK,et al. Exogenous exosomes from mice with acetaminophen-induced liver injury promote toxicity in the recipient hepatocytes and mice[J]. Sci Rep,2018,8(1):16070.
|
[31] MOTAWI TK,MOHAMED MR,SHAHIN NN,et al. Timecourse expression profile and diagnostic potential of a miRNA panel in exosomes and total serum in acute liver injury[J]. Int J Biochem Cell Biol,2018,100:11-21.
|
[32] de FREITAS R,BORTOLIN RH,LOPES MB,et al. Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with clopidogrel-induced hepatotoxicity in HepG2cells[J]. Front Pharmacol,2017,8:906.
|
[33] WU Y,GAO C,CAI S,et al. Circulating miR-122 is a predictor for virological response in CHB patients with high viral load treated with nucleos(t)ide analogs[J]. Front Genet,2019,10:243.
|
[34] CHENG JL,ZHAO H,YANG SG,et al. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT[J]. Hepatol Int,2018,12(3):277-287.
|
[35] LEE YS,KIM SY,KO E,et al. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells[J]. Sci Rep,2017,7(1):3710.
|
[36] AHMED EK,FAHMY SA,EFFAT H,et al. Circulating miR-210 and miR-1246 as potential biomarkers for differentiating hepatocellular carcinoma from metastatic tumors in the liver[J]. J Med Biochem,2019,38(2):109-117.
|
[37] ZHANG AB,PENG YF,JIA JJ,et al. Exosome-derived galectin-9 may be a novel predictor of rejection and prognosis after liver transplantation[J]. J Zhejiang Univ Sci B,2019,20(7):605-612.
|
[38] OHARA M,OHNISHI S,HOSONO H,et al. Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats[J]. Stem Cells Int,2018,2018:3212643.
|
[39] NONG K,WANG W,NIU X,et al. Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats[J]. Cytotherapy,2016,18(12):1548-1559.
|
[40] NOJIMA H,FREEMAN CM,SCHUSTER RM,et al. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate[J]. J Hepatol,2016,64(1):60-68.
|
[41] CHEN L,LU FB,CHEN DZ,et al. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis[J]. Mol Immunol,2018,93:38-46.
|
[42] LIU Y,LOU G,LI A,et al. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3inflammasome activation in macrophages[J]. EBio Medicine,2018,36:140-150.
|
[43] CHEN R,HUANG H,LIU H,et al. Friend or foe? evidence indicates endogenous exosomes can deliver functional gRNA and Cas9 protein[J]. Small,2019,15(38):e1902686.
|